Wegovy injection: Options, Costs, Benefits & Safety Considerations

Last updated: November 2, 2026

More than 40% of U.S. adults qualify for anti-obesity medication by BMI alone, yet most people who ask their doctor about Wegovy still leave the appointment confused about price, dosing, and whether the drug will actually work for their body. That confusion is the real barrier, not the science.

This guide on Wegovy injection: Options, Costs, Benefits & Safety Considerations breaks down what the medication does, what it costs in 2026, who qualifies, and what to expect if you start, stay on, or stop treatment.

Quick Answer

Wegovy (semaglutide) is a once-weekly injectable GLP-1 medication approved for chronic weight management and, in adults with cardiovascular disease, for reducing heart attack and stroke risk. List price is roughly $1,350 per month before savings programs, though manufacturer coupons, a new Medicare GLP-1 bridge, and insurance coverage can bring that much lower for eligible patients [1][2].

Key Takeaways

• Wegovy is semaglutide, dosed weekly via a pre-filled pen, approved for weight management and cardiovascular risk reduction [3][4].
• List price is about $1,350/month; NovoCare savings cards and a 2026 Medicare bridge program can cut costs significantly [1][5].
• Wegovy and Ozempic share the same active ingredient but different approved doses and labeled uses [3].
• Common side effects are gastrointestinal: nausea, diarrhea, constipation, and vomiting [3].
• Most people need a BMI of 30+, or 27+ with a weight-related condition, to qualify [3].
• Stopping Wegovy usually leads to significant weight regain within a year without lifestyle changes [6].
• Wegovy is not recommended during pregnancy or breastfeeding [3].

What Does Wegovy Actually Do and How Does It Work

Wegovy works by mimicking a natural gut hormone called GLP-1, which slows stomach emptying and signals the brain that you’re full. This reduces appetite and calorie intake over time, leading to gradual, sustained weight loss [3].

The active ingredient, semaglutide, also affects blood sugar regulation, which is why the same molecule treats both obesity (Wegovy) and type 2 diabetes (Ozempic) under different brand names and dosing schedules. In 2026, Novo Nordisk expanded the product line to include a higher-dose HD pen and an oral tablet version, giving patients more delivery options beyond the standard injection [3][7].

Choose the injectable pen if you want the most clinically established option with the longest safety track record. The oral tablet, covered in our semaglutide pills versus injections comparison, may suit people who are needle-averse, though injections remain the primary FDA-approved format for Wegovy specifically.

How Much Does a Wegovy Injection Cost Per Month

Wegovy’s list price is approximately $1,350 per month without insurance, but almost nobody pays that full amount if they use available savings tools [1][8]. With a NovoCare savings card, insured patients with coverage can pay as little as $0,$25 per month, while uninsured or underinsured patients may qualify for cash-pay pricing closer to $650,$850 through manufacturer programs [1][5].

A major 2026 development is the Medicare GLP-1 Bridge, a temporary program offering seniors access to GLP-1 medications for roughly $50 per month during 2026-2027 [2]. This matters because Medicare historically excluded weight-loss drugs from coverage, leaving many older adults paying out of pocket.

Decision rule: If you have commercial insurance with obesity-drug coverage, apply for the manufacturer savings card first. If you’re on Medicare, ask your prescriber about bridge program eligibility before assuming you’re locked out. For a full cost breakdown across GLP-1 brands, see our guide to GLP-1 weight loss cost.

Is Wegovy More Effective Than Ozempic for Weight Loss

Wegovy is specifically approved and dosed for weight management, while Ozempic is approved for type 2 diabetes; Wegovy’s maximum dose (2.4 mg, with a newer 7.2 mg option approved in some markets) is typically higher than Ozempic’s standard diabetes dosing [3][6].

Because Wegovy’s labeling and dose-escalation schedule are built around weight loss, doctors generally prescribe it over Ozempic when weight loss is the primary goal, even though many patients use Ozempic off-label for the same purpose. Our GLP-1 comparison guide breaks down how Wegovy stacks up against Zepbound and other options.

Common mistake: Assuming the two drugs are interchangeable at the same dose. They are not labeled the same way, and switching without medical guidance can cause unexpected side effects or inadequate dosing.

What Are the Most Common Side Effects People Experience With Wegovy

The most frequently reported side effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, and abdominal pain, especially during the first few months of dose escalation [3]. These symptoms often fade as the body adjusts.

Less common but more serious risks listed on the FDA label include pancreatitis, gallbladder problems, kidney issues from dehydration, and a boxed warning about thyroid C-cell tumors seen in rodent studies [3]. Anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not take Wegovy [3].

Edge case: If nausea becomes severe enough to prevent eating or drinking, contact your prescriber before your next dose, this may signal you’re escalating too fast.

What’s the BMI or Weight Requirement to Qualify for Wegovy

Wegovy is approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol [3]. It’s also approved for certain adolescents aged 12 and older meeting specific weight criteria [3].

If you’re close to the BMI 27 threshold but don’t have a qualifying condition, insurance is less likely to approve coverage, even if a doctor is willing to prescribe. Check our guide on GLP-1 eligibility for non-diabetics for a deeper look at qualifying pathways.

Can You Take Wegovy If You Have Type 2 Diabetes

Yes, Wegovy can be prescribed to people with type 2 diabetes, and it’s also FDA-approved to reduce cardiovascular risk in adults with established heart disease and obesity, regardless of diabetes status [4]. This cardiovascular indication, based on the SELECT trial, was a major 2024 label expansion that broadened who can access the drug under medical necessity [4].

Patients with diabetes should still monitor blood sugar closely when starting Wegovy, since combining it with insulin or sulfonylureas raises the risk of hypoglycemia [3]. If diabetes management is your primary concern rather than weight loss, Ozempic may be the more appropriate labeled choice, talk to your doctor about which indication fits your case.

What’s the Difference Between Wegovy and Other Weight Loss Medications

Wegovy (semaglutide) differs from Zepbound (tirzepatide) in its mechanism: Wegovy targets only the GLP-1 receptor, while Zepbound targets both GLP-1 and GIP receptors, which some studies suggest drives greater average weight loss [3]. Both are injectable, weekly, and FDA-approved for obesity management.

Feature	Wegovy	Zepbound	Ozempic
Active ingredient	Semaglutide	Tirzepatide	Semaglutide
Approved use	Weight management, CV risk reduction	Weight management	Type 2 diabetes
Mechanism	GLP-1 only	GLP-1 + GIP	GLP-1 only
Dosing frequency	Weekly	Weekly	Weekly

For a full rundown on tirzepatide-based options, see our Zepbound injection guide and tirzepatide cost breakdown.

How Often Do You Need to Inject Wegovy Each Week

Wegovy is injected once per week, on the same day each week, at any time of day, with or without food [3]. Doses are escalated gradually over several months, starting at 0.25 mg and increasing in steps up to the maintenance dose of 2.4 mg (or higher with the newer HD formulation) to reduce gastrointestinal side effects [3].

Quick example: If you inject every Monday morning, stick to that schedule even if you miss a week, the label specifies how many days you can safely delay before skipping or resuming at the next scheduled dose [3].

Will Insurance Cover My Wegovy Prescription

Coverage depends heavily on your plan: many commercial insurers now cover Wegovy when obesity-related criteria are met, but some employer plans explicitly exclude weight-loss drugs, and Medicare only recently gained a limited pathway through the 2026 bridge program [1][2]. Prior authorization is almost always required.

Decision rule: Call your insurer directly and ask specifically whether “anti-obesity medication” is covered under your pharmacy benefit, don’t rely on general diabetes drug coverage language, since Wegovy and Ozempic are billed differently. Our Trump Rx Prices 2026 guide covers recent federal pricing changes affecting GLP-1 access.

What Happens to Your Weight When You Stop Taking Wegovy

Most people regain a meaningful portion of lost weight within a year of stopping Wegovy, because the appetite-suppressing effect fades once semaglutide clears the body [6]. This is why many clinicians frame Wegovy as a long-term chronic disease treatment rather than a short course.

Maintaining the lifestyle changes built during treatment, portion awareness, protein intake, activity levels, can soften the rebound but rarely prevents it entirely without continued medication or a tapering strategy agreed upon with your doctor.

How Long Can You Safely Take Wegovy

Wegovy is approved for long-term, ongoing use in chronic weight management, and clinical trial data support continued use for years under medical supervision [3][6]. There is no fixed maximum duration specified on the label for adults without contraindications.

Common mistake: Stopping Wegovy abruptly after reaching a goal weight without a plan. Most specialists recommend discussing a maintenance strategy, whether that’s staying on a lower dose or transitioning to lifestyle-only management, before discontinuing.

Can You Use Wegovy If You’re Pregnant or Breastfeeding

No. Wegovy is not recommended during pregnancy, and the label advises stopping it at least two months before a planned pregnancy due to the time needed for the drug to clear the body [3]. Animal studies raised concerns about fetal risk, and there is insufficient human safety data.

There’s also no established safety data on semaglutide in breast milk, so most prescribers advise against use while breastfeeding and will discuss alternative weight management approaches during that period [3].

Why Isn’t My Wegovy Working Anymore

A plateau on Wegovy is common and usually reflects your body adapting metabolically, not a sign the drug has “stopped working.” Weight loss naturally slows after the first 6-12 months as your body reaches a new energy equilibrium [6].

Before assuming treatment failure, check these possibilities:

• Dose too low: You may not have reached the maintenance dose yet.
• Injection technique issues: Improper storage or injection site rotation can reduce absorption.
• Diet drift: Appetite suppression can mask gradual calorie creep over months.
• Underlying condition: Thyroid or hormonal issues can blunt results.

If a plateau persists despite proper dosing, ask your doctor about the higher-dose HD pen option or whether switching to a dual-agonist like Zepbound might work better for your biology [7].

How Do You Properly Store and Inject Wegovy at Home

Unopened Wegovy pens must be refrigerated between 36-46°F until first use; once in use, a pen can be stored at room temperature (up to 86°F) for a limited time specified on the label, then discarded [3]. Never freeze Wegovy, freezing destroys the medication.

Basic home injection steps:

1. Wash hands and check the pen for correct dose and clear, colorless liquid.
2. Choose an injection site: abdomen, thigh, or upper arm, rotating weekly.
3. Clean the skin and let it air dry.
4. Insert the pen fully and hold for the required count per the instructions.
5. Dispose of the needle in an FDA-cleared sharps container.

For visual step-by-step pen details, see our dedicated Wegovy weekly injection pen guide.

Frequently Asked Questions

Is Wegovy the same as Ozempic?
They share the same active ingredient, semaglutide, but Wegovy is approved for weight management and cardiovascular risk reduction, while Ozempic is approved for type 2 diabetes, with different dosing schedules [3].

How much weight can I expect to lose on Wegovy?
Weight loss varies by individual, diet, and activity level; clinical trials showed substantial average reductions in body weight over about a year of treatment, though real-world results differ person to person [6].

Does Wegovy help with heart health, not just weight?
Yes. The FDA expanded Wegovy’s label to include reducing the risk of heart attack, stroke, and cardiovascular death in adults with obesity and established heart disease, based on the SELECT trial [4].

What’s the newest Wegovy option in 2026?
Novo Nordisk introduced an HD pen with a higher maximum dose and continues developing an oral tablet form, giving patients more delivery choices beyond the standard injection [7].

Can I use GoodRx or coupons to lower my Wegovy cost?
Manufacturer savings cards through NovoCare are generally more valuable than third-party discount cards for Wegovy, especially for insured patients [1][5].

Is there a generic version of Wegovy?
No approved generic exists yet, though compounded semaglutide alternatives are available through some pharmacies; see our compounded semaglutide injections guide for details on how these differ from brand-name Wegovy.

What if Wegovy causes unbearable nausea?
Talk to your prescriber about slowing the dose escalation schedule rather than stopping altogether; most GI side effects improve once the body adjusts to a stable dose [3].

Conclusion

Wegovy remains one of the most effective FDA-approved tools for chronic weight management and cardiovascular risk reduction, but getting the most out of it means understanding the real costs, realistic side effects, and what happens after you stop. If you’re considering treatment, start by confirming your BMI eligibility, checking your insurance’s specific obesity-drug coverage, and asking about the 2026 Medicare bridge program if you’re a senior. Talk to a licensed prescriber about dosing, savings options, and whether Wegovy or an alternative GLP-1 fits your health profile best.

References

1. What to Pay for Wegovy. wegovy.com.
2. News Details. novonordisk.com.
3. 215256s015lbl. accessdata.fda.gov.
4. FDA Approves First Treatment Reduce Risk Serious Heart Problems Specifically Adults Obesity or. fda.gov.
5. Wegovy. novocare.com.
6. Wegovy. drugs.com.
7. News Details. novonordisk.com.
8. What Cost Wegovy 3579864. drugs.com.